NCT04087759View on ClinicalTrials.gov

A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

January 7, 2020

Study Completion Date

January 7, 2020

Conditions
Healthy
Interventions
DRUG

Bedaquiline (Test formulation)

Participants will receive bedaquiline orally.

DRUG

Bedaquiline (Reference formulation)

Participants will receive bedaquiline orally.

Trial Locations (1)

2060

SGS Life Science Services, Antwerp

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04087759 - A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult Participants | Biotech Hunter | Biotech Hunter